Guideline Summary: Labor Management, Pharmacologic Agents, and Analgesia

Labor Stages

First‑stage latent phase – Characterized by a flat cervical dilation slope, variable duration, and requires serial vaginal examinations every 2 hours to detect transition to active labor. 1
Active phase dilation rates – Expected minimum cervical dilation rates are ≥ 1.2 cm/h for nulliparous patients and ≥ 1.5 cm/h for multiparous patients; slower rates indicate protracted dilation. 1
Deceleration phase – Normally brief and often unnoticed; abnormal prolongation is defined as > 2–3 hours in nulliparous and > 1 hour in multiparous patients. 1
Second stage – Commences at complete cervical dilation and ends with delivery of the infant. 1
Third stage – Begins after infant delivery and concludes with placental delivery. [2][3]

Misoprostol (PGE₁) – A vaginal dose of 25 µg every 3–6 hours is effective for cervical ripening; a 50 µg dose every 6 hours may be used in selected cases but carries a higher risk of uterine hyperstimulation. It is contraindicated in patients with a prior cesarean section because of uterine‑rupture risk. [4][5]
Dinoprostone (PGE₂) – Available as a gel or vaginal insert; after administration, continuous fetal heart‑rate and uterine‑activity monitoring is required from 30 minutes to 2 hours (gel) or from placement until 15 minutes after removal (insert). [4][5]

Scheduled (ante‑partum) cesarean delivery – Initial IV bolus 1 IU, rescue bolus 3 IU if uterine tone remains inadequate after 2 minutes, followed by a maintenance infusion of 2.5–7.5 IU/h. The infusion rate must not exceed 1 IU per 10 seconds to avoid hemodynamic effects. [2][3]
Unscheduled (intrapartum) cesarean delivery – Initial IV bolus 3 IU, rescue bolus 3 IU if tone inadequate after 2 minutes, with a maintenance infusion of 7.5–15 IU/h. [2][3]
Low‑risk patients – A regimen of 0.5 IU IV followed by infusion is non‑inferior to a 5 IU IV bolus regarding uterine tone, need for additional uterotonics, and blood loss. 2

Utilizes dilute bupivacaine combined with fentanyl to minimize motor block; the goal is the lowest concentration that provides adequate analgesia. Timing should be individualized, not withheld solely based on cervical dilation, and CEI does not increase cesarean delivery rates. [6][7][8][9]

Provides rapid onset of analgesia; technique involves an intrathecal dose of local anesthetic plus opioid followed by placement of an epidural catheter for continuation. Recommended when labor duration may exceed the effect of a single spinal dose or when an operative delivery is possible. [6][7][9][10]11

Effective for time‑limited analgesia when a spontaneous vaginal delivery is anticipated; adding a local anesthetic prolongs duration and improves quality. Use pencil‑point needles to reduce post‑dural puncture headache. [6][7][9][10]

Results in fewer anesthetic interventions, lower local anesthetic doses, and less motor blockade compared with fixed‑rate infusions; may be employed with or without a background infusion. [6][9][7][10]

Local anesthetics – Bupivacaine (intermediate‑long duration; low‑concentration epidural for labor, hyperbaric for cesarean), Chloroprocaine (short‑acting, rapid onset for epidural or intrathecal), Lidocaine (intermediate duration). [11][6]
Opioids – Fentanyl (lipophilic, short‑acting; IV, epidural, or intrathecal) and Morphine (hydrophilic, long‑acting for postoperative analgesia). [6][11]
Adjuvants – Clonidine and Dexmedetomidine (α₂‑agonists providing analgesia, anxiolysis, and anti‑shivering via IV, epidural, or intrathecal routes). 11

Acetaminophen – 975–1000 mg oral preoperatively or IV after delivery. 8
NSAID (Ketorolac) – 15–30 mg IV administered at the end of surgery when not contraindicated. 8
Dexamethasone – Single intra‑operative dose as an analgesic adjuvant. 11
Intrathecal morphine – Considered the cornerstone of enhanced‑recovery protocols for cesarean delivery. [2][11]
If intrathecal morphine is omitted – Alternatives include wound infiltration, continuous wound infusion, or fascial‑plane blocks (e.g., transversus abdominis, erector spinae, quadratus lumborum). 2

Agent	Key Consideration	Evidence
Carboprost (PGF₂α)	May cause bronchospasm	[2][3]
Methylergonovine (Ergot alkaloid)	May cause hypertension	[2][3]
Carbetocin	Probably the most effective uterotonic; not available in the United States	[2][3]

High‑risk obstetric patients (e.g., twin gestation, preeclampsia, anticipated difficult airway, obesity) – Early placement of a neuraxial catheter is recommended to reduce the need for general anesthesia if an emergent procedure becomes necessary. [6][7][8][9]
Vaginal Birth After Cesarean (VBAC) – Neuraxial analgesia should be offered; early catheter placement is appropriate for later labor analgesia or operative delivery anesthesia. [6][9]
Failed induction management – After cervical ripening, membrane rupture, and uterine stimulant use, allow at least 12 hours before labeling the induction as “failed” and proceeding to cesarean delivery. 12